189 related articles for article (PubMed ID: 23927387)
21. The combined use of endometrial ablation or resection and levonorgestrel-releasing intrauterine system in women with heavy menstrual bleeding: A systematic review.
Oderkerk TJ; van de Kar MMA; van der Zanden CHM; Geomini PMAJ; Herman MC; Bongers MY
Acta Obstet Gynecol Scand; 2021 Oct; 100(10):1779-1787. PubMed ID: 34165779
[TBL] [Abstract][Full Text] [Related]
22. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
[TBL] [Abstract][Full Text] [Related]
23. Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis.
Roberts TE; Tsourapas A; Middleton LJ; Champaneria R; Daniels JP; Cooper KG; Bhattacharya S; Barton PM
BMJ; 2011 Apr; 342():d2202. PubMed ID: 21521730
[TBL] [Abstract][Full Text] [Related]
24. The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefit-risk review.
Kaunitz AM; Inki P
Drugs; 2012 Jan; 72(2):193-215. PubMed ID: 22268392
[TBL] [Abstract][Full Text] [Related]
25. Usual medical treatments or levonorgestrel-IUS for women with heavy menstrual bleeding: long-term randomised pragmatic trial in primary care.
Kai J; Middleton L; Daniels J; Pattison H; Tryposkiadis K; Gupta J;
Br J Gen Pract; 2016 Dec; 66(653):e861-e870. PubMed ID: 27884916
[TBL] [Abstract][Full Text] [Related]
26. Differences in continuation rates and early removal between contraceptive and therapeutic use of the levonorgestrel-releasing intrauterine system 52 mg.
Teunissen AM; Merry AHH; Devies IEC; Roumen FJME
Eur J Contracept Reprod Health Care; 2019 Dec; 24(6):449-456. PubMed ID: 31696740
[No Abstract] [Full Text] [Related]
27. User satisfaction with a levonorgestrel-releasing intrauterine system (LNG-IUS): data from an international survey.
Römer T; Linsberger D
Eur J Contracept Reprod Health Care; 2009 Dec; 14(6):391-8. PubMed ID: 19929641
[TBL] [Abstract][Full Text] [Related]
28. Two Years Follow-Up of Patients with Abnormal Uterine Bleeding after Insertion of the Levonorgestrel-Releasing Intrauterine System.
Cim N; Soysal S; Sayan S; Yildizhan B; Karaman E; Cetin O; Tolunay HE; Yildizhan R
Gynecol Obstet Invest; 2018; 83(6):569-575. PubMed ID: 29223999
[TBL] [Abstract][Full Text] [Related]
29. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
30. A case series on the use of levonorgestrel 52 mg intrauterine system after organ transplant.
Juliato CRT; Stahlschmidt P; Fernandes A; Monteiro I; Bahamondes L
Contraception; 2018 Sep; 98(3):252-254. PubMed ID: 29746814
[TBL] [Abstract][Full Text] [Related]
31. Hysterectomy, endometrial destruction, and levonorgestrel releasing intrauterine system (Mirena) for heavy menstrual bleeding: systematic review and meta-analysis of data from individual patients.
Middleton LJ; Champaneria R; Daniels JP; Bhattacharya S; Cooper KG; Hilken NH; O'Donovan P; Gannon M; Gray R; Khan KS; ; Abbott J; Barrington J; Bhattacharya S; Bongers MY; Brun JL; Busfield R; Sowter M; Clark TJ; Cooper J; Cooper KG; Corson SL; Dickersin K; Dwyer N; Gannon M; Hawe J; Hurskainen R; Meyer WR; O'Connor H; Pinion S; Sambrook AM; Tam WH; van Zon-Rabelink IA; Zupi E
BMJ; 2010 Aug; 341():c3929. PubMed ID: 20713583
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness analysis of levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.
Brown PM; Farquhar CM; Lethaby A; Sadler LC; Johnson NP
BJOG; 2006 Jul; 113(7):797-803. PubMed ID: 16827763
[TBL] [Abstract][Full Text] [Related]
33. Oral Progestogens Versus Levonorgestrel-Releasing Intrauterine System for Treatment of Endometrial Intraepithelial Neoplasia.
Marnach ML; Butler KA; Henry MR; Hutz CE; Langstraat CL; Lohse CM; Casey PM
J Womens Health (Larchmt); 2017 Apr; 26(4):368-373. PubMed ID: 27901412
[TBL] [Abstract][Full Text] [Related]
34. Progesterone/progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding.
Lethaby AE; Cooke I; Rees M
Cochrane Database Syst Rev; 2000; (2):CD002126. PubMed ID: 10796865
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of action of the levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding.
Cihangir U; Ebru A; Murat E; Levent Y
Int J Gynaecol Obstet; 2013 Nov; 123(2):146-9. PubMed ID: 24028852
[TBL] [Abstract][Full Text] [Related]
36. Endometrial adenocarcinoma following insertion of the levonorgestrel-releasing intrauterine system (mirena) in a 36-year-old woman.
Abu J; Brown L; Ireland D
Int J Gynecol Cancer; 2006; 16(3):1445-7. PubMed ID: 16803545
[TBL] [Abstract][Full Text] [Related]
37. Levonorgestrel-releasing intrauterine system vs. endometrial thermal ablation for menorrhagia.
Theodoridis TD; Zepiridis L; Zafrakas M; Grimbizis G; Tantsis A; Kyrou D; Bontis JN
Hormones (Athens); 2009; 8(1):60-4. PubMed ID: 19269922
[TBL] [Abstract][Full Text] [Related]
38. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
Sturridge F; Guillebaud J
Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
[TBL] [Abstract][Full Text] [Related]
39. Pregnancy outcomes associated with extended use of the 52-mg 20 μg/day levonorgestrel-releasing intrauterine system beyond 60 months: A chart review of 776 women in Brazil.
Bahamondes L; Fernandes A; Bahamondes MV; Juliato CT; Ali M; Monteiro I
Contraception; 2018 Mar; 97(3):205-209. PubMed ID: 29055780
[TBL] [Abstract][Full Text] [Related]
40. Use of a levonorgestrel 52-mg intrauterine system in the control of abnormal uterine bleeding in women with inherited bleeding disorders.
Campos RR; Baêta T; Silva-Filho A; Rezende SM; Rocha ALL
Contraception; 2020 Oct; 102(4):254-258. PubMed ID: 32470465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
